With the purpose of accelerating drug discovery.

GEN publishes a print edition 21 times a 12 months and has additional unique editorial content online, like information and analysis in addition to blogs, podcasts, webinars, polls, movies, and program notes. GEN’s unique information and technology concentrate includes the complete bioproduct life routine from early-stage R&D, to applied study including omics, biomarkers, along with diagnostics, to commercialization and bioprocessing.. Astrazeneca, Taiwan’s NRPB Release Drug Discovery Collaboration AstraZeneca and Taiwan’s National Study System for Biopharmaceuticals said today they will have launched an open up innovation analysis collaboration, with the purpose of accelerating drug discovery..

Big challenges from antibiotic resistant bacteria – Did you know resistant bacterias kill at least 25,000 people in the EU each year? – Did you know resistant bacteria could be transferred from pets to humans through meals? The Swedish Development and Analysis funders invite you to a press briefing and breakfast at European Technology Open Discussion board, ESOF 2012 in Dublin. Antibiotic resistant bacterias are raising and spreading at an alarming velocity. The bacterial development is mind-boggling our antibiotic defense. A lot more bacteria have become resistant to antibiotics leading to fatal consequences for thousands of people. We are in need of common responsibility and action for the advancement of brand-new effective antibiotics also to stop antibiotic misuse.